CD8A and neoplasm: CD8+ T cells play an important role in tumor cell killing and therapeutic sensitivity of ICIs (Fridman et al., 2017; Powles et al., 2014), and patients with high abundance of tumor-infiltrating T cells have a favored prognosis in BCa (Sharma et al., 2007).